Webinar: Drug metabolism using a chemosynthetic liver

23 August 2018 15:00-16:00, United Kingdom


Introduction

Chemosynthetic Livers: Predict, Prepare and Prove the Structure, Activity and Toxicity of Drug Metabolites 

 

Mukund S. Chorghade

 President and CSO

THINQ Pharmaceuticals, Inc.

 

 

 

RSCMetabolites are implicated in adverse drug reactions and are the subject of intense scrutiny in drug R&D. Present-day processes involving animal studies are expensive, labor-intensive and chemically inconclusive.   We report advances in proprietary in vitro green chemistry-based technology, mimicking in vivo metabolism of several chemical entities used in pharmaceuticals, cosmetics, and agrochemicals. Our catalysts enable prediction of metabolism patterns with soft-spot analysis and the methodology introduces new paradigms for drug discovery and drug-drug interactions for clinical diagnostics.   Our catalysts (azamacrocycles) are sterically protected and electronically activated, providing speed, stability and scalability. We predict structures of metabolites, prepare them on a large scale by oxidation, and elucidate chemical structures.  Comprehensive safety evaluation enables researchers to conduct more complete in vitro metabolism studies, confirm structure and generate quantitative measures of toxicity.
 
Speakers
Sponsorship & supporting organisations
Centre for Process Analytics and Control Technology (CPACT)
Venue

United Kingdom

Organised by
RSC Process Chemistry & Technology Group
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement Spotlight Advertisement

E-mail Enquiry
*
*
*
*